Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use - Guidance Implementation in Q1/Q2 Assessment
Author/sLi, Xinran
Date:12/06/2022
Meeting Name:FDA-CRCG Workshop on Excipients and Formulation Assessments of Complex Generic Products: Best Practices and Lessons Learned
State:
City:Virtual